HRK Produkte
(Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK))
Kategorien
This gene encodes a member of the BCL-2 protein family. Members of this family are involved in activating or inhibiting apoptosis. The encoded protein localizes to intracellular membranes. This protein promotes apoptosis by interacting with the apoptotic inhibitors BCL-2 and BCL-X(L) via its BH3 domain. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte HRK Kategorien
HRK Antikörper
High quality antibodies with extensive validation data.
HRK ELISA Kits
Reliable ELISA kits for a wide range of species.
Empfohlene HRK Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human, Mouse
Applikation
WB, IHC (p)
Validierungen
- (2)
Kat. Nr.
ABIN388104
Menge
400 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
ELISA, IHC
Validierungen
- (2)
Kat. Nr.
ABIN7243397
Menge
200 μL
Datenblatt
Datenblatt
Reaktivität
Mouse, Rat
Applikation
ELISA, IF (cc), IF (p), IHC (p), IHC (fro), ICC
Validierungen
- (1)
Kat. Nr.
ABIN2559409
Menge
100 μL
Datenblatt
Datenblatt
Empfohlene HRK ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Validierungen
Kat. Nr.
ABIN1120325
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Mouse
Analytical Method
Validierungen
Kat. Nr.
ABIN1120326
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Rat
Analytical Method
Validierungen
Kat. Nr.
ABIN1120327
Menge
96 tests
Datenblatt
Datenblatt
Neueste Publikationen zu unseren HRK Produkten
: "High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia." in: Leukemia, Vol. 30, Issue 6, pp. 1273-81, (2016) (PubMed).: "Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response." in: Cancer research, Vol. 76, Issue 6, pp. 1313-9, (2016) (PubMed).
: "Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas." in: Acta neuropathologica, Vol. 110, Issue 4, pp. 402-10, (2005) (PubMed).
: "Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32." in: Cell death and differentiation, Vol. 11, Issue 7, pp. 771-81, (2004) (PubMed).
: "Up-regulation of Hrk, a regulator of cell death, in retinal ganglion cells of axotomized rat retina." in: Neuroscience letters, Vol. 318, Issue 2, pp. 77-80, (2002) (PubMed).
: "Interleukin 3-dependent activation of DREAM is involved in transcriptional silencing of the apoptotic Hrk gene in hematopoietic progenitor cells." in: The EMBO journal, Vol. 20, Issue 9, pp. 2286-92, (2001) (PubMed).
: "Cell death in the third millennium." in: Cell death and differentiation, Vol. 7, Issue 1, pp. 2-7, (2000) (PubMed).
Synonyme und alternative Namen zu HRK
harakiri, BCL2 interacting protein (HRK), harakiri, BCL2 interacting protein (contains only BH3 domain) (Hrk), harakiri, BCL2 interacting protein (Hrk), AI838259, Bid3, DP5, Dp5, HARAKIRI, harakiriBezeichner auf Proteinebene für HRK
- BCL2-interacting protein
- BH3-interacting domain-containing protein 3
- activator of apoptosis Hrk
- activator of apoptosis harakiri
- death protein 5
- neuronal death protein DP5
- BH3 interacting (with BCL2 family) domain, apoptosis agonist
- BH3 interacting domain 3
Sie sind hier:
